Literature DB >> 4856949

Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.

C P Cerini, J Arguedas, G Hernandez, P Frickey, A V Douglas.   

Abstract

A new, further attenuated measles vaccine, developed by propagation of Edmonston B measles virus in the chorioallantoic membrane in ovo, has been clinically evaluated in children and found to compare favorably with a commercially available product. The vaccine is prepared in chick embryo tissue culture and appears to possess noteworthy stability at 4 C.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856949      PMCID: PMC380131          DOI: 10.1128/am.27.4.763-766.1974

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  5 in total

1.  AN ACCELERATED STORAGE TEST FOR PREDICTING THE STABILITY OF SUSPENSIONS OF MEASLES VIRUS DRIED BY SUBLIMATION IN VACUO.

Authors:  D GREIFF; W A RIGHTSEL
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

2.  Hemagglutination and hemagglutination-inhibition with measles virus.

Authors:  L ROSEN
Journal:  Virology       Date:  1961-01       Impact factor: 3.616

3.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

Review 4.  Measles vaccines.

Authors:  J A Dudgeon
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

5.  Adaptation of measles virus to the chorio-allantoic membrane of chicken embryos in ovo.

Authors:  V J Cabasso; P H Frickey
Journal:  Nature       Date:  1966-06-18       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.